Skip to main content
Premium Trial:

Request an Annual Quote

BGI-Complete Genomics Deal Clears Last Regulatory Hurdle

NEW YORK (GenomeWeb News) – The State Administration of Foreign Exchange of the People's Republic of China has approved BGI's proposed $118 million acquisition of Complete Genomics, the companies said today, setting the stage for the completion of the acquisition.

The deal has now received all necessary regulatory approvals, BGI and Complete said. The Ministry of Commerce of the People's Republic of China approved the deal a few weeks ago, and US regulators cleared the deal in January.

The cash tender offer for the deal has been extended several times and is now set to expire at 11:59 PM EDT, March 14.